The introduction of nicotinamide as being a nicotine substitute in e-cigarette and smokeless products signifies an important regulatory obstacle for the FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to work as a sedative at significant dosages6. The claims made by Nicotine River, ECBlend, and other distributors